ALEXA SMITH: Open Payments
NPI 1669011300 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 49 payments from 14 companies in 2025. Trend: 2023 $749 · 2024 $860 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $154 |
| ABBVIE INC. | 13 | $154 |
| Celltrion USA Inc. | 4 | $65 |
| VIVUS LLC | 3 | $53 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 4 | $41 |
| Braintree Laboratories, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $24 |
| COLOPLAST CORP | 1 | $22 |
Products named: XIFAXAN, CREON, VEGZELMA, ZENPEP, VOQUEZNA, SUTAB, XELJANZ, RINVOQ.
Industry payments across TX — which companies pay providers there.
